General Catalyst Group Management, LLC
Source: SEC Form 13F · as of Mar 2026General Catalyst Group Management, LLC holds 3 biotech & pharma companies tracked by BioSniper, totaling $68.6M in value as of Mar 2026 (SEC Form 13F).
Companies held
3
Total value held
$68.6M
BioSniper AIPage evidence connected
Prepared research question
What matters most for ArriVent BioPharma, Inc. (AVBP)—catalysts, financial risk and supporting evidence?
Run cited research
Traceable citations · Unknowns marked
| Company | Shares | Value |
|---|---|---|
| AVBPArriVent BioPharma, Inc. | 1,494,786 | $34.5M |
| MAZEMaze Therapeutics, Inc. | 1,035,910 | $30.9M |
| EIKNEikon Therapeutics Inc. | 305,233 | $3.2M |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.